Subcutaneous zygomycosis: report of 10 cases from two institutions in North India.
BACKGROUND
Subcutaneous zygomycosis is an uncommon condition observed in tropics. Few series have been published, particularly from the northern regions of India.


OBJECTIVE
The aim of this study was to describe clinical, investigative and therapeutic details in subcutaneous zygomycosis observed in two teaching hospitals in Delhi.


METHODS
Ten patients seen over a period of 10 years (1999-2009) form the material for this report.


RESULTS
There were four children and six adults. In four children, the presentation was a subcutaneous localized mass or gradually spreading plaque. In the others, it was observed over nasal region of face, spreading inward into mucosal sites and paranasal sinuses, and outward to the contiguous areas. Regional lymphadenopathy was present in two with facial lesions. Majority showed a granulomatous infiltrate with admixture of other cells, mainly eosinophils. Aseptate or poorly septate hyphae were observed in seven. In one patient in whom no hyphae were observed, there was dense perivascular inflammation. Organisms were cultured from four patients, Basidiobolus ranarum in two and Syncephalastrum racemosum in two. The main therapy used was a saturated solution of potassium iodide (KI). Four received only KI of which two attained cure after 3 months and 9 months respectively, and the other two showed signs of regression. In one boy subsidence was associated with reduced circumference of thigh. Ketoconazole or itraconazole was given with KI to hasten regression when response was slow or there were side-effects to KI.


CONCLUSIONS
Awareness and early recognition will prevent disfigurement produced by advanced disease, misdiagnosis and unnecessary surgical intervention.
Ramesh
V
V
Department of Dermatology & STD, Safdarjang Hospital & Vardhman Mahavir Medical College and All India Institute of Medical Sciences, New Delhi 110 029, India. weramesh@hotmail.com
Ramam
M
M
Capoor
M R
MR
Sugandhan
S
S
Dhawan
J
J
Khanna
G
G
D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D003881:Dermatomycoses / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology; D004359:Drug Therapy, Combination; D020091:Entomophthorales / Q000302:isolation & purification; D004804:Eosinophils / Q000473:pathology; D005260:Female; D006801:Humans; D007194:India / Q000453:epidemiology; D017964:Itraconazole / Q000627:therapeutic use; D007654:Ketoconazole / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009090:Mucorales / Q000302:isolation & purification; D011193:Potassium Iodide / Q000627:therapeutic use*; D012189:Retrospective Studies; D012867:Skin / Q000382:microbiology / Q000473:pathology; D055815:Young Adult; D020096:Zygomycosis / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology
D011193:Potassium Iodide; D017964:Itraconazole; D007654:Ketoconazole